Orthopedic Surgery Doctors in Fairfield, CT Accepting Medicare

25 Orthopedic Surgery doctors found. Showing 21 - 25

Adam Driesman, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 305 Black Rock Tpke, Fairfield, CT 06825 Phone: 203-337-2600

Robert A Stanton, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 305 Black Rock Tpke, Orthopaedic Specialty Group, Fairfield, CT 06825 Phone: 203-337-2600    Fax: 203-337-2666

Cullen K Griffith, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 305 Black Rock Tpke, Fairfield, CT 06825 Phone: 203-337-2600    Fax: 203-337-2666

Murray A Morrison, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 75 Kings Highway Cutoff, Orthopaedic Specialty Group, Fairfield, CT 06824 Phone: 203-337-2600

John Warren Axline, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 401 Silver Spring Rd, Fairfield, CT 06824 Phone: 203-259-2427    Fax: 203-372-1985

News Archive

Taiho receives CHMP positive opinion on Teysuno in combination with cisplatin for advanced gastric cancer

Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the Committee for Medicinal Products for Human Use (CHMP), a division of the European Medicines Agency (EMA), has issued an opinion recommending approval of Teysuno™ (S-1), a novel oral anti-cancer agent, intended for the treatment of advanced gastric cancer in adults when given in combination with cisplatin.

Acadia second quarter revenue increases 58.1% to $100.5 million

Acadia Healthcare Company, Inc. today announced financial results for the second quarter ended June 30, 2012.

2009 Gold eHealthcare Leadership Award presented to NYU Langone Medical Center's educational website

The 2009 Gold eHealthcare Leadership Award has been awarded to NYU Langone Medical Center's educational website and blog, "Clinical Correlations," under the direction of Editor In Chief Neil Shapiro, MD.

Health Canada approves Genzyme's Lemtrada for adults with relapsing remitting multiple sclerosis

Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.

Read more Medical News

› Verified 3 days ago

• 1
• 2(current)